The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease
Open accessAbstract
BACKGROUND: Sickle cell disease is characterized by a hypercoagulable state as a result of multiple factors, including chronic hemolysis and circulating cell-derived microparticles. There is still no consensus on the cellular origin of such microparticles and the exact mechanism by which they may enhance coagulation activation in sickle cell disease. DESIGN AND METHODS: In the present study, we analyzed the origin of circulating microparticles and their procoagulant phenotype during painful crises and steady state in 25 consecutive patients with sickle cell disease. RESULTS: The majority of microparticles originated from platelets (GPIIIa,CD61) and erythrocytes (glycophorin A,CD235), and their numbers did not differ significantly between crisis and steady state. Erythrocyte-derived microparticles strongly correlated with plasma levels of markers of hemolysis, i.e. hemoglobin (r=-0.58, p<0.001) and lactate dehydrogenase (r=0.59, p<0.001), von Willebrand factor as a marker of platelet/endothelial activation (r=0.44, p<0.001), and D-dimer and prothrombin fragment F1+2 (r=0.52, p<0.001 and r=0.59, p<0.001, respectively) as markers of fibrinolysis and coagulation activation. Thrombin generation depended on the total number of microparticles (r=0.63, p<0.001). Anti-human factor XI inhibited thrombin generation by about 50% (p<0.001), whereas anti-human factor VII was ineffective (p>0.05). The extent of factor XI inhibition was associated with erythrocyte-derived microparticles (r=0.50, p=0.023). CONCLUSIONS: We conclude that the procoagulant state in sickle cell disease is partially explained by the factor XI-dependent procoagulant properties of circulating erythrocyte-derived microparticles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546
Stuart, M. J., & Nagel, R. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17192-4 · Cited by 819
Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation
Nieuwland, R., Böing, A., Romijn, F., Hack, C. E., Sturk, A., & Berckmans, R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615646 · Cited by 651
Self-citationCellular origin and procoagulant properties of microparticles in meningococcal sepsis
Nieuwland, R., Berckmans, R. J., McGregor, S., Böing, A. N., Th. M. Romijn, F. P. H., Westendorp, R. G. J., Hack, C. E., & Sturk, A. (2000) · Blood · doi:10.1182/blood.v95.3.930.003k46_930_935 · Cited by 574
Self-citationShet, A. S., Aras, O., Gupta, K., Hass, M. J., Rausch, D. J., Saba, N., Koopmeiners, L., Key, N. S., & Hebbel, R. P. (2003) · Blood · doi:10.1182/blood-2003-03-0693 · Cited by 539
The hypercoagulable state in thalassemia
Eldor, A., & Rachmilewitz, E. A. (2002) · Blood · doi:10.1182/blood.v99.1.36 · Cited by 503
Cellular microparticles: new players in the field of vascular disease?
Diamant, M., Tushuizen, M. E., Sturk, A., & Nieuwland, R. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01355.x · Cited by 364
Self-citationNieuwland, R., Berckmans, R. J., Rotteveel-Eijkman, R. C., Maquelin, K. N., Roozendaal, K. J., Jansen, P. G. M., Have, K. T., Eijsman, L., Hack, C. E., & Sturk, A. (1997) · Circulation · doi:10.1161/01.cir.96.10.3534 · Cited by 345
Self-citationBorne, P. A. V. D., Meijers, J. C. M., & Bouma, B. N. (1995) · Blood · doi:10.1182/blood.v86.8.3035.3035 · Cited by 292
Self-citationHugel, B., Socié, G., Vu, T., Toti, F., Gluckman, E., Freyssinet, J.-M., & Scrobohaci, M.-L. (1999) · Blood · doi:10.1182/blood.v93.10.3451.410k27_3451_3456 · Cited by 259
Cited by
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
van der Pol, E., Böing, A. N., Harrison, P., Sturk, A., & Nieuwland, R. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005983 · Cited by 1,754
Self-citationExtracellular vesicles in physiological and pathological conditions
Yuana, Y., Sturk, A., & Nieuwland, R. (2013) · Blood Reviews · doi:10.1016/j.blre.2012.12.002 · Cited by 569
Self-citationOptical and non‐optical methods for detection and characterization of microparticles and exosomes
VAN DER POL, E., HOEKSTRA, A. G., STURK, A., OTTO, C., VAN LEEUWEN, T. G., & NIEUWLAND, R. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04074.x · Cited by 535
Self-citationMicroparticles: biomarkers and beyond
Burger, D., Schock, S., Thompson, C. S., Montezano, A. C., Hakim, A. M., & Touyz, R. M. (2013) · Clinical Science · doi:10.1042/cs20120309 · Cited by 362
Camus, S. M., De Moraes, J. A., Bonnin, P., Abbyad, P., Le Jeune, S., Lionnet, F., Loufrani, L., Grimaud, L., Lambry, J.-C., Charue, D., et al. (2015) · Blood · doi:10.1182/blood-2014-07-589283 · Cited by 262
Metadata
- Authors
- van Beers, E. J., Schaap, M. C. L., Berckmans, R. J., Nieuwland, R., Sturk, A., van Doormaal, F. F., Meijers, J. C. M., Biemond, B. J., & on behalf of the CURAMA study group*
- Venue
- Haematologica
- Published
- 2009-10-08
- Volume
- 94
- Issue
- 11
- Pages
- 1513-1519
- ISSN
- 0390-6078 (ISSN-L)
- 1592-8721
- OpenAlex
- W2108644172
- Cited by
- 272
- References
- 21
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. https://app.cochat.ai/papers/10.3324/haematol.2009.008938
- The paper
- van Beers, E. J., Schaap, M. C. L., Berckmans, R. J., Nieuwland, R., Sturk, A., van Doormaal, F. F., Meijers, J. C. M., Biemond, B. J., & on behalf of the CURAMA study group*. (2009). Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica. https://doi.org/10.3324/haematol.2009.008938
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.